Suggested Readings

Human narcolepsy is linked to degeneration of both locus coeruleus and hypocretin neurons.

Thannickal TC, et al. Nat Commun. 2026;17(4978):1-12.

The burden of narcolepsy symptoms from patients' perspective: a narrative qualitative study.

Hlodak J, et al. Sleep Breath. 2025;29(4):231.

Comorbidity of obstructive sleep apnea and narcolepsy: a challenging diagnosis and complex management.

Miano S, et al. Sleep Med X. 2024;8:100126.

Idiopathic hypersomnia: neurobiology, diagnosis, and management.

Morse AM, Naik S. CNS Drugs. 2023;37(4):305-322.

Symptom severity and treatment satisfaction in patients with idiopathic hypersomnia: the Real World Idiopathic Hypersomnia Outcomes Study (ARISE).

Schneider LD, et al. Nat Sci Sleep. 2023;15:89-101.

The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality.

Ruoff C, Rye D. Curr Med Res Opin. 2016;32(10):1611-1622.

Narcolepsy.

Slowik JM, et al. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026.

Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a real-world evidence study

Ben-Joseph RH, et al. Sleep. 2023;46(10):zsad161.

Narcolepsy Is Associated With Subclinical Cardiovascular Disease as Early as Childhood: A Big Data Analysis

Kaufman CN, et al. J Am Heart Assoc. 2025;14(12):e039899.

186 Real-World Risk of Sodium-Associated Negative Clinical Outcomes Among Individuals With Narcolepsy in the United States

Markt SC, et al. World Sleep. 2025. Singapore.

Cardiovascular Risks in People With Narcolepsy: Expert Panel Consensus Recommendations

Kwon Y, et al. J Am Heart Assoc. 2024;13(16):e035168.

Effects of High- Versus Low-Sodium Oxybate on Blood Pressure in Patients With Narcolepsy

White WB, et al. Hypertension. 2025;82(12):2162-2171.

(#125) Greater Than 9 Gram Dosage of Low-Sodium Oxybate in Study Participants With Narcolepsy: Effectiveness and Safety Results From the DUET Study

Simmons J, et al. Psych Congress 2025.

Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study.

Dauvilliers Y, et al. Lancet Neurol. 2022;21(1):53-65.

Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia.

Morse AM, et al. J Clin Sleep Med. 2023;19(10):1811-1822.

0639 Long-term safety and timing of adverse events with low-sodium oxybate in a phase 3 idiopathic hypersomnia study.

Bogan R, et al. Sleep. 2024;47(suppl 1):A273-A274.

Linked Resources

PRACTICE GUIDELINES & CONSENSUS STATEMENTS

The AASM International Classification of Sleep Disorders, Third Edition, Text Revision (ICSD-3-TR)

American Academy of Sleep Medicine. American Academy of Sleep Medicine; 2023.

Dosing optimization of low-sodium oxybate in narcolepsy and idiopathic hypersomnia in adults: consensus recommendations.

Morse AM, et al. Neurol Ther. 2024;13(3):785-807.

Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline.

Maski K, et al. J Clin Sleep Med. 2021;17(9):1881-1893.

CLINICAL PRACTICE TOOLS AND RESOURCES

Epworth Sleepiness Scale (ESS)

North America Predictor of Sleepiness (NAPS) Scale

Lee-Chiong T. Sleep Med Clin. 2012;7(2):xv–xvi.

Pediatric Daytime Sleepiness Scale

Drake C, et al. Sleep. 2003;26(4):455-458.

Pediatric Hypersomnolence Survey

Boston Children’s Hospital.

Idiopathic Hypersomnia Sleep Severity (IHSS) Scale

PATIENT RESOURCES AND ADVOCACY ORGANIZATIONS

Project Sleep.

Narcolepsy Link.

National Sleep Foundation.

Narcolepsy Network.

American Academy of Sleep Medicine (AASM).

Hypersomnia Foundation.

 

Related activities
 
1.00 CME/ANCC

Activity 1 - Morning Clinic

A Day in the Life of a Sleep Specialist: Comprehensive Care for Narcolepsy and Idiopathic Hypersomnia

Faculty: Karl Doghramji, MD, FAASM, DFAPA; Paul P. Doghramji, MD, FAAFP
Release: 11/17/2026
Expiration: 11/17/2027